Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies AH Bio Fund II, L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Behzad Aghazadeh - $36.26M in SCTX purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $15.00M in SCTX purchases and sales in the last 12 months
- Carl L. Gordon - $15.00M in SCTX purchases and sales in the last 12 months
- Svetlana Lucas - $45K in SCTX purchases and sales in the last 12 months
- David Parrot - $40K in SCTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is AH Bio Fund II, L.P.?
AH Bio Fund II, L.P. is an investment firm, tracked as 10% Owner of Scribe Therapeutics, Inc. (SCTX). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did AH Bio Fund II, L.P. last file a Form 4?
The only primary Form 4 on record is dated 29 July 2026.
Has AH Bio Fund II, L.P. been buying or selling stock?
Recorded transactions: 1 open-market purchase ($5.00M) and 0 open-market sales across all tracked filings.
